Xenon Pharmaceuticals Inc.
XENE
$55.23
-$2.67-4.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.45% | -29.32% | -32.43% | -21.44% | -1.75% |
| Total Receivables | -6.67% | -13.43% | 28.60% | 938.30% | 68.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 50.83% | 264.00% | 103.65% | 7.24% | 14.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -11.75% | -27.21% | -31.29% | -20.03% | -1.50% |
|
|
|||||
| Total Current Assets | -11.75% | -27.21% | -31.29% | -20.03% | -1.50% |
| Net Property, Plant & Equipment | -15.75% | -13.97% | -11.84% | -5.27% | -3.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.62% | 121.28% | 148.34% | 145.68% | 109.34% |
| Total Assets | -20.67% | -27.28% | -23.72% | -19.12% | -17.27% |
|
|
|||||
| Total Accounts Payable | -23.37% | -16.06% | -49.59% | 7.03% | -41.03% |
| Total Accrued Expenses | 53.68% | 47.02% | 29.14% | 19.79% | 37.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.91% | 7.79% | 7.75% | 4.46% | 5.39% |
| Total Finance Division Other Current Liabilities | -94.50% | -78.61% | 66.67% | 6,087.74% | 1,538.62% |
| Total Other Current Liabilities | -94.50% | -78.61% | 66.67% | 6,087.74% | 1,538.62% |
| Total Current Liabilities | 17.43% | 29.10% | 5.63% | 44.13% | 30.50% |
|
|
|||||
| Total Current Liabilities | 17.43% | 29.10% | 5.63% | 44.13% | 30.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -16.14% | -18.66% | -16.40% | -19.87% | -20.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.89% | 26.86% | 0.85% | 25.53% | 17.24% |
|
|
|||||
| Common Stock & APIC | 10.32% | 4.23% | 4.07% | 4.17% | 3.94% |
| Retained Earnings | -38.46% | -36.74% | -36.09% | -35.26% | -35.23% |
| Treasury Stock & Other | 120.78% | -64.30% | 105.11% | 52.74% | -1,993.51% |
| Total Common Equity | -22.94% | -29.87% | -24.89% | -20.70% | -18.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -22.94% | -29.87% | -24.89% | -20.70% | -18.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.94% | -29.87% | -24.89% | -20.70% | -18.65% |
|
|
|||||